Unraveling the Mystery of Alpha-Synuclein and Mitochondrial dysfunction in Parkinson's Disease.

被引：0
|
作者：
Zhang, X. [1 ,2 ,3 ]
Ruan, L. [2 ,3 ,4 ]
Zhu, J. [2 ,3 ]
Li, R. [1 ,2 ,3 ]
机构：
[1] Diana Helis Henry Med Res Fdn, New Orleans, LA USA
[2] Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol BCMB Grad Program, Baltimore, MD USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P3332
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    [J]. MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [32] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
  • [33] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    [J]. NATURE, 1997, 388 (6639) : 232 - 233
  • [34] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [35] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
    Shannon, Daniel
    Bugada, John-Paul
    Collins, Ethan
    Fischer, Ellie
    Hellard, Delaney
    Hoffman, Trevor
    Kellogg, Nick
    Peters, Kyle
    Poetker, Garret
    Young, Logan
    Diao, JiaJie
    [J]. FASEB JOURNAL, 2020, 34
  • [36] Alpha-synuclein and presynaptic functionImplications for Parkinson’s disease
    Simon Lykkebo
    Poul Henning Jensen
    [J]. NeuroMolecular Medicine, 2002, 2 : 115 - 129
  • [37] Role of alpha-synuclein and tau in Parkinson's disease
    Trojanowski, JQ
    [J]. MOVEMENT DISORDERS, 2004, 19 : S2 - S2
  • [38] The central role of alpha-synuclein in Parkinson's disease
    Halliday, G.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 54 - 54
  • [39] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179
  • [40] Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management
    Phillipson, Oliver T.
    [J]. AGEING RESEARCH REVIEWS, 2017, 40 : 149 - 167
12345